Marco Tognetti

5PUBLICATIONS
20CO-AUTHORS
Central nervous systemIndustrial molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2025
Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging.

Aida Kamalian, Polina Shichkova, Marco Tognetti

|Sep 26, 2025
A Flexible End-to-End Automated Sample Preparation Workflow Enables Standardized and Scalable Bottom-up Proteomics.

Sandra Schär, Luca Räss, Liliana Malinovska

|Jun 06, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.

Lacey J Padrón, Deena M Maurer, Mark H O'Hara

|May 23, 2022
Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area.

Marco Tognetti, Kamil Sklodowski, Sebastian Müller

|Oct 18, 2021
Cell-to-cell and type-to-type heterogeneity of signaling networks: insights from the crowd.

Attila Gabor, Marco Tognetti, Alice Driessen

Pageof 1

Frequent Collaborators

3 joint publications

Lukas Reiter

2 joint publications

Roland Bruderer

2 joint publications

Polina Shichkova

1 joint publications

Attila Gabor